To investigate the role of EGFR in Src-mediated lapatinib resistance, we evaluated the effect of the anti-EGFR mAb cetuximab combined with lapatinib on signal transduction of lapatinib-resistant breast cancer cells. The gene discussed is SRC; the disease is breast carcinoma.